No results for ‘’
Novartis India Ltd
₹2046.80
(1.70%)
Thu, 24 Sept 2026, 08:34 pm
Novartis India Ltd Price to Book Ratio
The Novartis India Ltd Price to Book Ratio is a key financial metric used by investors to evaluate Novartis India Ltd's valuation, profitability, and overall financial performance. Tracking the Novartis India Ltd Price to Book Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Novartis India Ltd (NSE: NOVARTIND, BSE: 500672) is currently trading at ₹2046.80, with a market capitalization of ₹5137.78Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Novartis India Ltd Price to Book Ratio is essential for fundamental analysis.
Novartis India Ltd Price to Book Ratio Current Value
The current Novartis India Ltd Price to Book Ratio stands at 0.
The Novartis India Ltd Price to Book Ratio remains stable, indicating consistent financial performance.
Novartis India Ltd Price to Book Ratio Historical Trend
The Novartis India Ltd Price to Book Ratio has shown the following historical trend:
The decline in Novartis India Ltd Price to Book Ratio indicates improving financial efficiency or better earnings growth.
What Novartis India Ltd Price to Book Ratio Indicates for Investors
The Novartis India Ltd Price to Book Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/B ratio shows how the market values company assets relative to book value.
Novartis India Ltd Price to Book Ratio Analysis Summary
The Novartis India Ltd Price to Book Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Novartis India Ltd Price to Book Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Novartis India Ltd Price to Book Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.